# QHSLab, Inc. (USAQ)

- SEC CIK: 0000856984 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000856984))
- Full page: https://inspectstocks.com/stocks/usaq
- Data as of: newest filing used 2026-11-12; latest fiscal period ended 2026-09-30

## Grade

**B+** on the balance-sheet rubric used for lenders, 4 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | $437.6K |  |
| Earnings growing overall | passed | $437.6K | -$597.9K |
| Earnings growing recently | failed | $437.6K | $457.4K |
| Earns well on its assets | passed | 25.0% |  |
| Book value per share growing | passed | $0.08 | $0.01 |

Business quality (the + / − mark): 4 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | 14.8% |  |
| Healthy profit margin | passed | 14.8% |  |
| Strong operating margin | failed | -2.2% |  |
| Good return on equity | passed | 26.9% |  |
| Debt under control | passed | 0.07 |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $3M |
| Net income, trailing twelve months | $437.6K |
| Net margin | 14.8% |
| Operating margin | -2.2% |
| Return on equity | 26.9% |
| Debt to equity | 0.07 |
| Diluted EPS, trailing twelve months | $0.03 |

## More on this company

- [Overview](https://inspectstocks.com/stocks/usaq)
- [Financial statements](https://inspectstocks.com/stocks/usaq/financials)
- [Competitors](https://inspectstocks.com/stocks/usaq/peers)
- [Earnings](https://inspectstocks.com/stocks/usaq/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.